content

Thermo Fisher Scientific Officially Opens New Site for Manufacturing COVID-19 Sample Collection Products

Thermo Fisher Scientific Inc., the world leader in serving science, officially cut the ribbon on its new $40 million facility in Lenexa, Kansas dedicated...

Catalent Biologics Invests $50 Million to Add Third High-Speed Vial Line at its Bloomington, Indiana, Facility

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

Novartis, AMSP collaborate to facilitate supply of COVID-19 related medicines to AU member states & Caricom countries

Novartis and the African Union (AU) through the Africa Medical Supplies Platform (AMSP) have announced a new collaboration to facilitate the supply of medicines...

CSafe Global Expands Further into Asia Opening Hub Operations in Taipei, Taiwan

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, has once again expanded their global reach and local...

Stevanato Group signs an agreement with Nelson Labs to provide best-in-class Extractables & Leachables testing services at its US Technology Excellence Center

Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global...

Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced it has signed two agreements in Hainan, China with PT Bio Farma,...

EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer

AstraZenecaโ€™s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read